Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents
Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-05-09. On CanQuery you can follow the original downloads. Files are available in English and French.
After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly associated with melatonin use in children and adolescents ranging from newborn to 18 years old (pediatric population), Health Canada did a review of this safety issue in this age group.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2024-05-09
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents (French, HTML) HTML · Download HTML
- Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents (English, HTML) HTML · Download HTML